Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -2.72%88.12B | 5.25%373.57B | 14.16%90.58B | 22.21%354.92B | 11.76%95.35B | 24.36%93.85B | 18.74%86.39B | 39.48%79.34B | 24.32%290.42B | 36.52%85.31B |
| Cost of revenue | -3.13%78.58B | 3.57%326.23B | 12.58%81.12B | 18.16%314.97B | 7.49%81.58B | 18.49%82.38B | 17.22%78.96B | 33.94%72.06B | 25.71%266.57B | 31.41%75.9B |
| Gross profit | 0.83%9.54B | 18.50%47.34B | 29.81%9.46B | 67.55%39.95B | 46.12%13.76B | 93.18%11.47B | 37.61%7.43B | 135.97%7.29B | 10.66%23.84B | 98.82%9.42B |
| Operating expense | -1.85%4.67B | 6.54%18.69B | 15.05%4.76B | 6.24%17.54B | 9.18%4.57B | 8.81%4.41B | 4.80%4.44B | 2.13%4.13B | 12.38%16.51B | 8.45%4.18B |
| Operating profit | 3.55%4.87B | 27.85%28.65B | 49.14%4.71B | 205.65%22.41B | 75.63%9.2B | 274.24%7.06B | 156.69%2.99B | 429.44%3.16B | 6.98%7.33B | 494.32%5.24B |
| Net non-operating interest income (expenses) | -23.78%125M | -26.96%737M | 10.81%164M | 344.49%1.01B | 75.74%239M | 260.26%281M | 1,523.81%341M | 1,950.00%148M | 297.39%227M | 1,260.00%136M |
| Non-operating interest income | -4.74%201M | -11.19%1.06B | 8.21%211M | 151.91%1.19B | 51.05%287M | 151.56%322M | 296.91%385M | 242.11%195M | 208.50%472M | 375.00%190M |
| Non-operating interest expense | 61.70%76M | 50.00%270M | 0.00%47M | -26.53%180M | -11.11%48M | -18.00%41M | -42.11%44M | -27.69%47M | -8.58%245M | 80.00%54M |
| Total other finance cost | ---- | --49M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net investment income | -137.91%-2.2B | -111.96%-1.67B | -35.78%5.8B | 68.17%13.99B | 466.77%7.05B | 40.03%-5.42B | -41.77%3.33B | -13.13%9.03B | -12.10%8.32B | -78.86%1.24B |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 701M | 7,383.33%437M | 0 | -112.00%-6M | 0 | 0 | 0 | -133.33%-6M | -91.55%50M | -161.54%-16M |
| Income from associates and other participating interests | 60.71%-77M | -246.73%-690M | -6,433.33%-196M | -186.15%-199M | 419.23%135M | -309.76%-344M | 128.26%13M | -103.45%-3M | -33.81%231M | -82.78%26M |
| Special income (charges) | -1,200.00%-13M | -108.69%-6.22B | 99.15%-1M | -180.26%-2.98B | -5,308.33%-2.5B | -5,271.43%-362M | 0.00%-2M | 89.44%-118M | -53,100.00%-1.06B | 536.36%48M |
| Less:Other special charges | 1,200.00%13M | -100.20%-1M | -99.07%1M | -53.95%490M | 45.45%-24M | 5,728.57%394M | 209.09%12M | -90.41%108M | 17,833.33%1.06B | -1,566.67%-44M |
| Less:Write off | ---- | 149.76%6.22B | --0 | --2.49B | 63,200.00%2.52B | ---- | ---- | 211.11%10M | --0 | -150.00%-4M |
| Other non-operating income (expenses) | -46.51%46M | -41.17%353M | -43.05%86M | 45.63%600M | -9.65%103M | 155.42%212M | -34.95%134M | 1,577.78%151M | -12.90%412M | -35.96%114M |
| Income before tax | -67.29%3.46B | -37.98%21.59B | -14.54%10.56B | 124.55%34.82B | 109.52%14.22B | 121.12%1.43B | -3.52%6.81B | 46.62%12.36B | -11.96%15.5B | -4.62%6.79B |
| Income tax | -61.04%1.37B | -58.57%7.28B | 8.51%3.52B | 229.82%17.57B | 472.21%11.47B | 123.51%496M | 1.85%2.37B | 4.28%3.24B | -18.61%5.33B | -28.66%2B |
| Net income | -70.41%2.08B | -17.00%14.31B | -22.75%7.04B | 69.45%17.24B | -42.43%2.75B | 120.04%933M | -6.13%4.44B | 71.37%9.12B | -8.04%10.18B | 11.03%4.78B |
| Net income continuous operations | -70.41%2.08B | -17.00%14.31B | -22.74%7.04B | 69.44%17.24B | -42.44%2.75B | 120.03%933M | -6.15%4.44B | 71.37%9.12B | -8.03%10.18B | 11.05%4.78B |
| Noncontrolling interests | 45.16%45M | 16.78%167M | -16.22%31M | -13.33%143M | 150.77%33M | -76.33%40M | -41.07%33M | 640.00%37M | 153.85%165M | -3,350.00%-65M |
| Net income attributable to the company | -70.92%2.04B | -17.29%14.14B | -22.79%7.01B | 70.84%17.1B | -43.87%2.72B | 118.53%894M | -5.74%4.41B | 70.84%9.08B | -8.99%10.01B | 12.57%4.85B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -70.92%2.04B | -17.29%14.14B | -22.79%7.01B | 70.84%17.1B | -43.87%2.72B | 118.53%894M | -5.74%4.41B | 70.84%9.08B | -8.99%10.01B | 12.57%4.85B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -70.19%40.78 | -14.91%278.01 | -20.91%136.81 | 71.32%326.71 | -42.82%52.79 | 118.52%17.03 | -5.75%83.91 | 70.76%172.98 | -9.02%190.7 | 12.54%92.33 |
| Diluted earnings per share | -70.19%40.78 | -14.91%278.01 | -20.91%136.81 | 71.32%326.71 | -42.81%52.79 | 118.52%17.03 | -5.75%83.91 | 70.76%172.98 | -9.02%190.7 | 12.52%92.3139 |
| Dividend per share | 0 | 36.36%75 | 0 | 83.33%55 | 50.00%30 | 0 | 150.00%25 | 0 | 20.00%30 | 100.00%20 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |